Biotech • Organoids
Parallel Bio develops an organoid-based immune system platform enhanced by AI to improve drug discovery and testing processes.
Genetic biomarkers • Microbial DNA
Alphabiome specializes in using AI to analyze the human microbiome for genetic biomarkers that predict drug efficacy, advancing precision medicine.
Biotechnology • Cell Therapies
Stately Bio develops cell therapies using a machine learning-powered live-cell imaging platform to enhance process development and quality control for biopharma companies.
AI precision medicine • Diagnostic tool
Ataraxis AI develops AI-powered diagnostic tools to improve the accuracy and personalization of cancer treatment, starting with breast cancer diagnostics.
AI technology • Drug rescue
Ignota Labs uses AI technology to rescue and revive failing drug candidates by identifying and resolving drug toxicity issues.